REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,424,026 | +88.8% | 484,972 | +82.4% | 0.00% | +100.0% |
| Q2 2023 | $7,110,685 | -13.4% | 265,820 | -29.8% | 0.00% | 0.0% |
| Q1 2023 | $8,207,472 | +318.0% | 378,923 | +359.6% | 0.00% | – |
| Q4 2022 | $1,963,697 | -23.0% | 82,439 | -36.2% | 0.00% | -100.0% |
| Q3 2022 | $2,550,000 | +565.8% | 129,298 | +558.4% | 0.00% | – |
| Q2 2022 | $383,000 | -82.7% | 19,639 | -77.4% | 0.00% | – |
| Q1 2022 | $2,217,000 | -66.7% | 86,921 | -67.2% | 0.00% | – |
| Q4 2021 | $6,664,000 | +101.5% | 264,712 | +120.1% | 0.00% | – |
| Q3 2021 | $3,308,000 | +1.9% | 120,246 | +17.6% | 0.00% | – |
| Q2 2021 | $3,246,000 | -68.7% | 102,267 | -54.8% | 0.00% | -100.0% |
| Q1 2021 | $10,376,000 | +785.3% | 226,151 | +663.9% | 0.00% | – |
| Q4 2020 | $1,172,000 | +298.6% | 29,606 | +250.7% | 0.00% | – |
| Q3 2020 | $294,000 | -51.0% | 8,442 | -69.2% | 0.00% | – |
| Q1 2020 | $600,000 | – | 27,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |